CIP2A and non-small cell lung carcinoma: This study reports, for the first time, that CuB suppressed the proliferation of GR NSCLC cells in vitro and in vivo by inducing lysosome-mediated EGFR degradation and by downregulating the CIP2A/PP2A/Akt signaling axis.